- Home
- AMSS vs ALGS Comparison
AMSS vs ALGS Comparison
Compare AMSS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMSS | ALGS |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.6M | 34.6M |
| IPO Year | 2026 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AMSS | ALGS |
|---|---|---|
| Price | $0.35 | $5.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $52.38 |
| AVG Volume (30 Days) | ★ 140.7K | 36.2K |
| Earning Date | 08-14-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,186,000.00 |
| Revenue This Year | $3.71 | $1,562.10 |
| Revenue Next Year | $20.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $3.98 |
| 52 Week High | $2.44 | $13.69 |
Technical Indicators
Market Signals| Indicator | AMSS | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 21.86 | 44.69 |
| Support Level | N/A | $5.18 |
| Resistance Level | $0.81 | $6.91 |
| Average True Range (ATR) | 0.07 | 0.33 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 1.82 | 37.40 |
Price Performance
Historical ComparisonAbout AMSS AMASS Brands Inc. Common Stock
Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.